- State of the Life Sciences Industry, Q4 2025 Review - Unveils Key Trends and Opportunities in Pharma, Biopharma, Medical Devices, Cell Biology
- MannKind to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
- Sitryx to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
- Stoked Bio Secures Exclusive Global License to Develop a Promising New Therapy for Crohn’s Disease
- MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
- aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
- NervGen Pharma to Participate at Upcoming Investor Conferences
